NRSA Training Core

印第安纳州临床和转化科学研究所（CTSI）在装备TL 1前 博士（9年）和博士后培训生（4年）通过其职业发展，教育和 研究培训（CERT）计划。首先，CERT已通过9项资助培训了86名CTSI博士前学员 自行车.博士前课程完成者继续研究高水平的中位数百分比研究时间 的60%。大多数人仍在学术或研究岗位上。二是CERT培养博士后10名 学员超过3个资助周期，大多数方案完成者保留在学术职位上， 平均90%的时间用于研究。第三，我们的TL 1项目在以下方面存在着实质性的多样性： 性别（57.3%），少数民族（12.5%）和科学学科（27个不同的学科， 博士前和8个不同学科的博士后学员）。此外，实习生研究的类型跨越 跨T1到T4转化研究范围。TL 1 NRSA培训核心的四个具体目标 在本申请中提出的是：1）增加我们的基础计划的灵活性和范围， 特别是通过异步和/或在线战略，向新的科学受众（例如，牙科， 药剂学、兽医学、视光学、专职医疗），以及在培训初期给予学员的照顾。（二） 最大限度地提高TL 1培训的职业发展部分，包括基本支持（例如，融资写作 技能、生物统计学和导师培训）、突出的知识和技能以及有针对性的培训，以填补 临床和转化科学的劳动力，其中CERT计划特别强大（使用大数据， 执行科学、社区参与和交流以及药物开发）。3)发展 在3个新领域的研究培训：团队科学，创业精神和体验式学习。4)追求 区域和国家CTSA合作，以实现更大的创新和影响。指导我们的关键模型 战略举措是我们在所有CTSI活动中采用的“4D”持续创新周期： 设计、演示、复制和传播。我们还制定了创新举措， 为更广泛的传播提供示范方案。这些措施包括：a）I军团培训; B）国家 与行业合作伙伴协调体验式培训机会; c）混合博士后培训 学术界和行业之间，社区，政府，或医疗保健合作伙伴。我们终于有计划了 进一步加强招聘和留住代表性不足的少数群体科学家。我们正在加强 在翻译研究伦理学的新课程，负责任地进行研究的指示，以及 使用通用的评估工具加上新的指标进行评估。

The Indiana Clinical and Translational Sciences Institute (CTSI) has a sustained record of equipping TL1 pre- doctoral (for 9 years) and postdoctoral trainees (for 4 years) through its Career development, Education and Research Training (CERT) Program. First, CERT has trained 86 CTSI predoctoral trainees over 9 funding cycles. Predoctoral program completers continue in research a high level with a median percent research time of 60%. The majority remain in academic or research positions. Second, CERT has trained 10 postdoctoral trainees over 3 funding cycles with most program completers retained in academic positions and spending a median of 90% of their time in research. Third, there has been substantial diversity in our TL1 program in terms of gender (57.3%), underrepresented minorities (12.5%), and scientific disciplines (27 different disciplines for predoctoral and 8 different disciplines for postdoctoral trainees). Also, the type of trainee research spans across the T1 to T4 translational research spectrum. The four specific aims of the TL1 NRSA Training Core proposed in this application are to: 1) Increase the flexibility and reach of our foundational programs, particularly through asynchronous and/or online strategies, outreach to new scientific audiences (e.g., dental, pharmacy, veterinary medicine, optometry, allied health) and attention to trainees earlier in the pipeline. 2) Maximize the career development components of TL1 training, including essential support (e.g., grant writing skills, biostatistics, and mentor training), salient knowledge and skills, and targeted training to fill gaps in the clinical and translational science workforce where the CERT program is especially strong (using big data, implementation science, community engagement and communication, and drug development). 3) Develop research training in 3 new areas: team science, entrepreneurship, and experiential learning. 4) Pursue regional and national CTSA collaborations for greater innovation and impact. The key model that guides our strategic initiatives is the continuous innovation cycle of “4Ds” that we adopt in all of our CTSI activities: Design, Demonstrate, Duplicate, and Disseminate. We also created innovative initiatives that could serve as model programs for dissemination more broadly. These include a) an I-Corps training; b) national coordination of experiential training opportunities with industry partners; c) hybrid postdoctoral training between the academia and an industry, community, government, or health care partner. Finally, we have plans for further enhancing recruitment and retention of underrepresent minority scientists. We are enhancing instructions in the responsible conduct of research with a new course in translational research ethics, and evaluations with Common Metrics plus novel metrics.